ARKG vs. ARKB
ARKG (ARK Genomic Revolution Multi-Sector ETF) and ARKB (ARK 21Shares Bitcoin ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while ARKB is a Cryptocurrency fund tracking the CME CF Bitcoin Reference Rate - New York Variant. ARKG is actively managed, while ARKB is passively managed. Over the past year, ARKG returned 52.71% vs -39.74% for ARKB. At a 0.38 correlation, their price movements are largely independent. ARKG charges 0.75%/yr vs 0.21%/yr for ARKB.
Performance
ARKG vs. ARKB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 24.30% return, which is significantly higher than ARKB's -28.79% return.
ARKG
- 1D
- -1.07%
- 1M
- 17.41%
- YTD
- 24.30%
- 6M
- 19.48%
- 1Y
- 52.71%
- 3Y*
- 3.17%
- 5Y*
- -16.56%
- 10Y*
- 8.67%
ARKB
- 1D
- -3.18%
- 1M
- -17.72%
- YTD
- -28.79%
- 6M
- -28.93%
- 1Y
- -39.74%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG vs. ARKB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 24.30% | 23.04% | -26.95% |
ARKB ARK 21Shares Bitcoin ETF | -28.79% | -6.59% | 86.54% |
Correlation
The correlation between ARKG and ARKB is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Jan 11, 2024 | 0.38 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. ARKB — Risk / Return Rank
ARKG
ARKB
ARKG vs. ARKB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK 21Shares Bitcoin ETF (ARKB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKG | ARKB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.15 | ||
| Sortino ratioReturn per unit of downside risk | +3.17 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 0.86 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 1.93 | -0.77 | +2.69 |
| Martin ratioReturn relative to average drawdown | 4.58 | -1.30 | +5.89 |
Loading charts...
Drawdowns
ARKG vs. ARKB - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than ARKB's maximum drawdown of -52.04%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKB.
Loading charts...
Drawdown Indicators
| ARKG | ARKB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -52.04% | -31.55% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | -52.04% | +24.53% |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -67.78% | -50.41% | -17.37% |
Average DrawdownAverage peak-to-trough decline | -36.02% | -16.87% | -19.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.53% | 30.54% | -19.01% |
Volatility
ARKG vs. ARKB - Volatility Comparison
ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.19% compared to ARK 21Shares Bitcoin ETF (ARKB) at 13.08%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than ARKB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKG | ARKB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.19% | 13.08% | +2.11% |
Volatility (6M)Calculated over the trailing 6-month period | 30.91% | 34.51% | -3.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.54% | 44.12% | -1.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.93% | 50.05% | -4.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.29% | 50.05% | -8.76% |
ARKG vs. ARKB - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is higher than ARKB's 0.21% expense ratio.
Dividends
ARKG vs. ARKB - Dividend Comparison
Neither ARKG nor ARKB has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKB ARK 21Shares Bitcoin ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
Frequently Asked Questions
ARKG and ARKB have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (15.19%) compared to ARKB (13.08%). In terms of maximum drawdown, ARKG dropped -83.59% vs ARKB's -52.04%.
On 1-year performance, ARKG leads with 52.71% vs -39.74% for ARKB. On fees, ARKB is cheaper at 0.21% per year. On volatility, ARKB has been the lower-risk option at 13.08%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, ARKG has performed better with a 52.71% return vs -39.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKB is cheaper with a 0.21% expense ratio, compared with 0.75% for ARKG.
ARKG and ARKB have nearly identical dividend yields, around 0.00%.
ARKG is categorized as Health & Biotech Equities, while ARKB is Cryptocurrency. Their fees differ too: 0.75% for ARKG and 0.21% for ARKB.
ARKG currently has the higher Sharpe Ratio (1.25 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKG and ARKB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer